Valuation: Hugel, Inc.

Market Cap 1,820B 1.35B 1.21B 1.12B 1.02B 1.92B 128B 1.96B 13.49B 5.28B 66.92B 5.08B 4.97B 214B P/E 2026 *
13.8x
P/E 2027 * 10.3x
Enterprise Value 1.28B 950K 848K 788K 717K 1.35M 89.96M 1.37M 9.47M 3.7M 46.94M 3.56M 3.49M 150M EV / Sales 2026 *
2.53x
EV / Sales 2027 * 1.81x
Free-Float
45.22%
Yield 2026 *
-
Yield 2027 * -
1 day-2.32%
1 week-7.82%
Current month-6.23%
1 month-28.45%
3 months-27.84%
6 months-36.05%
Current year-26.90%
1 week 163,700
Extreme 163700
182,400
1 month 163,700
Extreme 163700
233,500
Current year 163,700
Extreme 163700
308,500
1 year 163,700
Extreme 163700
308,500
3 years 131,600
Extreme 131600
392,000
5 years 99,700
Extreme 99700
392,000
10 years 75,865.91
Extreme 75865.908
392,000
Manager TitleAgeSince
Director of Finance/CFO 61 -
Chief Tech/Sci/R&D Officer 54 -
Chief Executive Officer 49 -
Director TitleAgeSince
Director/Board Member 54 28/04/2022
Director/Board Member 56 28/04/2022
Director/Board Member 51 28/04/2022
Date Insider Type Main position Quantity % Market Cap. Importance
20/05/25 Exercice 1,200 0.0095%
20/05/25 Sell 1,200 0.0095%
19/05/25 Exercice

Chairman

31,510 0.2500%
Change 5-day change 1-year change 3-year change Capi.($)
-2.32%-7.82%-38.17%+17.50% 1.35B
+3.55%+7.01%+51.42%+105.45% 1,116B
-0.25%-1.25%+32.49%+61.48% 610B
-0.03%+4.03%+25.28%+91.54% 501B
-1.48%+1.97%+72.62%+39.59% 358B
-0.75%+5.20%+31.93%+49.28% 366B
-1.24%+4.30%+19.05%+42.45% 288B
-1.75%+3.78%-0.81%+13.49% 261B
+1.86%+6.53%+45.98%+52.77% 235B
+2.49%+6.98%+33.03%+102.67% 195B
Average -0.41%+3.96%+27.28%+57.62% 393.11B
Weighted average by Cap. -0.16%+4.93%+38.16%+71.59%

Financials

2026 *2027 *
Net sales 504B 375M 335M 311M 283M 532M 35.52B 542M 3.74B 1.46B 18.53B 1.41B 1.38B 59.31B 646B 481M 429M 399M 363M 683M 45.53B 695M 4.79B 1.87B 23.76B 1.8B 1.77B 76.02B
Net income 148B 110M 98.19M 91.26M 83.01M 156M 10.42B 159M 1.1B 429M 5.44B 413M 404M 17.39B 199B 148M 132M 123M 111M 210M 13.99B 214M 1.47B 576M 7.3B 554M 543M 23.37B
Net Debt -544B -404M -361M -335M -305M -574M -38.3B -584M -4.03B -1.58B -19.98B -1.52B -1.49B -63.94B -651B -485M -433M -402M -366M -688M -45.9B -700M -4.83B -1.89B -23.95B -1.82B -1.78B -76.64B
Projected Income Statement - Annual - Hugel, Inc.
Logo Hugel, Inc.
Hugel Inc is a Korea-based company mainly engaged in the manufacture and sale of biopharmaceutical products. The Company is mainly engaged in the research, development, manufacturing, and sales of biopharmaceuticals utilizing type A botulinum toxin derived from the microorganism clostridium botulinum, as well as hyaluronic acid–based tissue‑restoration biomaterial filler products. In addition, the Company sells botulinum toxin products, hyaluronic acid fillers, cosmetics, skin boosters, and lifting threads. The Company distributes its products in domestic and overseas markets.
Employees
620
Date Price Change Volume
15/10/26 ₩168,500.00 -2.32% 43,550
14/10/26 ₩172,500.00 +1.53% 46,666
13/10/26 ₩169,900.00 -5.61% 68,154
12/10/26 ₩180,000.00 -1.53% 64,190
08/10/26 ₩182,800.00 -0.44% 54,306
Trader
Investor
Global
Quality
ESG MSCI
B
MarketScreener Ratings - Hugel, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
168,500.00KRW
Average target price
305,647.06KRW
Spread / Average Target
+81.39%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Hugel, Inc.
  1. Stock Market
  2. Stocks
  3. A145020 Stock